Function Health is a platform that provides patients with access to over 160 lab tests at a single cost of $499 per year. These tests helps people at every life stage understand their current health, ...
Something big is looming in Harbinger Health’s future, and the company has now secured a sizable funding round to help get it there. Harbinger is developing a suite of liquid biopsy tests plus an ...
Freenome, an early cancer detection company developing blood-based screening tests, today is reporting the improved clinical performance of an updated version of its SimpleScreen™ CRC test. In data ...
SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 /PRNewswire/ -- Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from new and ...
PALO ALTO, Calif.--(BUSINESS WIRE)--Exai Bio today announced new data demonstrating that its novel RNA-based and AI-driven liquid biopsy platform can detect breast cancer at the earliest stages and ...
Please provide your email address to receive an email when new articles are posted on . mPATH Health has modules for identifying patients in need of colorectal, breast and lung cancer screening. mPATH ...
MONTREAL--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC), a leader in breast health technology and diagnostics, will feature its latest breast cancer detection technology during the 2024 Society of ...
A sponge-like gold nanoparticle platform could deliver faster, more accurate, and less invasive ovarian cancer diagnostics.
Development and real-world deployment of an optical character recognition (OCR)-enabled One-ID digital cervical cancer screening platform (web console + WeChat Mini Program). Phase I comprised system ...
An AI-powered lung cancer screening analysis software by South Korean company Coreline Soft has been added to the medical AI platform of global pharmaceutical firm Bayer. Its flagship product, AVIEW ...
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback